Guest User 1/29/24 Guest User 1/29/24

Monogram Health and Blue Cross Blue Shield of Arizona Partner to Improve Chronic Kidney Disease Outcomes

Partnership in delivering high quality, affordable care to BCBSAZ Health Choice Pathway HMO D-SNP members managing polychronic kidney disease

NASHVILLE, Tenn., and PHOENIX, Az. (January 29, 2024) —Blue Cross Blue Shield of Arizona (AZ Blue) today announced a partnership with Monogram Health, the nation’s leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease. Through this partnership, AZ Blue will use Monogram’s extensive network of in-home providers and support services to improve the care of their members.

“We’re proud to embark on this value-based care journey with Monogram Health to provide improved patient experiences, achieve better health outcomes and reduce variability in care,” said Shawn Nau, General Manager, Medicaid Segment at Blue Cross Blue Shield of Arizona. “We are firmly committed to delivering innovative services, personalized care management and support to the members we serve across Arizona. By combining AZ Blue’s high-value, cost-effective product with Monogram’s innovative, evidence-based approach to in-home care delivery, we’ll be able to dramatically improve the quality of life for our members navigating complex chronic and end stage kidney disease.”

As part of this collaboration, Monogram Health will assume full financial risk for BCBSAZ’s Health Choice Pathway D-SNP Product members with kidney disease. This unique partnership will give this population across eight counties in Arizona access to Monogram’s suite of specialized clinical and support services including evidence-based clinical pathways and protocols, in-home specialty care, complex case and disease management, and comprehensive medication therapy management.

Monogram, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services, utilizes evidence-based, whole-person care which has been shown to dramatically improve patient outcomes, experience and quality of life while reducing medical costs across the health care continuum.

“Through our value-based risk platform, we are transforming the way care is delivered to highest cost and most complex kidney patients,” said Dr. Aash Shah, Chief Growth Officer of Monogram Health. “We’re excited to partner with Blue Cross Blue Shield of Arizona, home to our operations hub, to extend our reach to vulnerable populations who deserve best-in-class care so they can enjoy healthier, happier, and more fulfilling lives.”

About Monogram Health
Monogram Health is a leading value-based provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions, notably, chronic kidney and end stage kidney disease. Through its unique in-home integrated provider services, Monogram Health and its employed providers treat CKD, ESKD and their prevalent co-morbidities including complex metabolic, pulmonary, and cardiovascular diseases. The company deploys a technology-driven array of clinical programs including comprehensive case management, disease management, utilization management, and medication therapy management to enable the delivery of value-based care. Based in Nashville, Tenn., and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans, integrated delivery systems, and risk-bearing entities to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit here.

About Blue Cross Blue Shield of Arizona
Blue Cross ® Blue Shield ® of Arizona (AZ Blue) is committed to helping Arizonans get healthier faster and stay healthier longer. With a mission to inspire health and make it easy, AZ Blue offers health insurance and related services to nearly 2 million customers. AZ Blue, a non-profit company, is an independent licensee of the Blue Cross Blue Shield Association. The company and its subsidiaries employ nearly 3,000 people in its Phoenix, Flagstaff, and Tucson offices. To learn more, visit azblue.com or connect with us on social media: Instagram, Twitter, LinkedIn or Facebook.

# # #

For Media Inquiries:
Kyle Cooksey
Chief Experience Officer
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

H5587_D38575PY24_M

Guest User 1/16/24 Guest User 1/16/24

Point32Health and Monogram Health Expand Collaboration Aimed at Improving Chronic Kidney Care

CANTON, Mass. and NASHVILLE, Tenn. (January 16, 2024) — Point32Health, the parent company of Tufts Health Plan and Harvard Pilgrim Health Care, today announced an expansion of its relationship with Monogram Health, the nation’s leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease to include members in its Tufts Health Direct population. Point32Health and Monogram began working together in 2022 to improve early access to kidney care for Harvard Pilgrim Health Care and Tufts Health commercial members.

“At Point32Health, we are committed to helping our members manage their health through tailored solutions which contribute to their overall wellness,” said Glenn Pomerantz, MD, chief medical officer of Point32Health. “We are excited about expanding our collaboration with Monogram Health, which helps us provide our members suffering from kidney disease with a more innovative care model, that could slow down disease progression and lead to better health outcomes.”

Through the expanded collaboration, Monogram Health will assume full financial risk for Tufts Health Direct members with kidney disease, delivering industry-leading in-home specialty care services, promoting better patient outcomes while improving affordability. More than 37 million Americans live with chronic kidney disease with communities of color being disproportionately impacted, as African Americans are about 3.5 times more likely and Hispanics approximately twice as likely to develop end-stage renal disease.

“This powerful collaboration with Point32Health expands Monogram’s ability to transform health care for CKD and ESKD patients in the commercial space,” said Aash Shah, MD, chief growth officer of Monogram Health. “Working with New England’s most iconic nonprofit health care organizations, we will improve the patient experience and quality of life for those affected by kidney disease.”

# # #

About Point32Health

Point32Health is a leading, health and wellbeing organization, delivering a better health care experience to our members and the communities we serve. One of the top twenty health plans in the United States, Point32Health builds on the quality of our founding organizations, Tufts Health Plan and Harvard Pilgrim Health Care.

At Point32Health, we believe that everyone should have equitable access to affordable, high-quality health care, regardless of their age, race, ethnicity, socioeconomic status, orientation, gender identity or ability. We offer a diverse range of health plans that help improve the health and wellness of the 2 million members we serve. Every day, we work to deliver on our purpose of guiding and empowering healthier lives for everyone.

We are proud that our Harvard Pilgrim Health Care Commercial Combined HMO and POS plans in Massachusetts and Maine, our Exchange HMO plans in Massachusetts and Maine, as well as Tufts Health Plan’s Medicaid and Exchange HMO plans, have received full Health Equity Accreditation from the National Committee for Quality Assurance (NCQA).*

*NCQA’s Health Equity Accreditation program

About Monogram Health

Monogram Health is a leading value-based provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions, notably, chronic kidney and end stage kidney disease. Through its unique in-home integrated provider services, Monogram Health and its employed providers treat CKD, ESKD and their prevalent co-morbidities including complex metabolic, pulmonary, and cardiovascular diseases. The company deploys a technology-driven array of clinical programs including comprehensive case management, disease management, utilization management, and medication therapy management to enable the delivery of value-based care. Based in Nashville, Tenn., and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans, integrated delivery systems, and risk-bearing entities to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit here.

# # #

For Media Inquiries:
Kyle Cooksey
Chief Experience Officer
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 1/8/24 Guest User 1/8/24

Monogram Health and Millennium Physician Group Partner to Improve Chronic Kidney Disease Outcomes for Several Thousand Patients Across Florida

Value-based organizations collaborate to deliver high quality, affordable care to Florida patients managing complex chronic conditions

NASHVILLE, Tenn., and Fort Myers, Fl. (January 8, 2024) — Monogram Health, the nation’s leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney (CKD) and end stage kidney disease (ESKD), and Millennium Physician Group, a leading value-based physician organization with over 800 providers across the Southeast, announced today a partnership to deliver high quality care to Millennium’s patients with CKD and ESKD. The multi-year partnership integrates Millennium’s high-quality physicians and advanced providers with Monogram’s extensive network of in-home nephrology and specialty care providers to create a next-generation care model that will improve outcomes for thousands of patients across Florida.

Millennium’s patients who are living with CKD and ESKD and related chronic conditions will be referred to the program, affording them access to Monogram’s suite of specialized clinical resources and support services inclusive of evidence-based clinical protocols, complex case and disease management, utilization management/quality assurance, and medication therapy management.

“We’re honored to partner with a leading physician organization like Millennium,” said Monogram Chief Growth Officer Aash Shah, MD, JD. “Providing Monogram’s specialty care services as a direct extension of Millennium’s high-quality physicians and advanced providers is a winning model for patients with kidney disease who deserve best-in-class care so they can enjoy healthier, happier, and more fulfilling lives.”

“We are very excited with this partnership that will provide timely and expert care in the appropriate setting for this extremely vulnerable population,” said Millennium Chief Medical Officer Alejandro Perez-Trepichio, MD. “Since Monogram cares for patients primarily in the home, they will ensure continuity of services in the field, operating in tandem with our healthcare professionals to provide individualized attention to each patient. Through close collaboration and a patient-centered approach, our unwavering dedication to delivering exceptional care will be evident to our patients, as a true connection to a healthier life.”

To learn more about how to access Monogram Health’s services, ask your Millennium PCP (844.CALL.MPG (844.225.5674)), contact Monogram Health at 855-212-2273, or visit MonogramHealth.com.

About Monogram Health

About Millennium

Founded in Port Charlotte in 2008, and now headquartered in Fort Myers, Millennium Physician Group has quickly become the leading independent physician group with more than 800 healthcare providers across the Southeast. Services center on primary care and are complemented by specialty care, walk-in centers, radiology and lab services, physical therapy, telehealth, wellness programs, home health, hospital care, and much more. Nationally recognized as a leader in value-based care with consistently high levels of physician engagement, Millennium aims to create a genuinely connected healthcare experience for patients by providing a comprehensive and coordinated approach to healthcare and be Your Connection to a Healthier Life.

# # #

Media Contact:

Monogram Health

Kyle Cooksey, Chief Experience Officer
kyle.cooksey@monogramhealth.com, 615-485-5999

Millennium Physician Group

Jacqueline Cardillo, Chief of Staff, Culture / Communications / Executive Office

jacqueline.cardillo@mpgus.com, 914-584-4025

Guest User 12/4/23 Guest User 12/4/23

Monogram Health Welcomes Greg Hicks to Executive Leadership Team

NASHVILLE, Tenn. (Dec. 4, 2023) — Monogram Health, the nation’s leading value-based multispecialty provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease, has hired Greg Hicks as Chief Human Resources Officer. Hicks is a strategic business executive with in-depth expertise across all facets of corporate human resources, positioning human capital for high-growth services companies.

“Greg has a proven track record of successfully leading in diverse healthcare organizations. He will help create great value for Monogram Health by developing a differentiated employee experience that drives our mission and preserves our culture,” said Monogram Health CEO and Co-Founder Mike Uchrin.

Hicks most recently served as The Cigna Group’s SVP & Human Resources Officer of Cigna Healthcare, and also led their Talent Strategy and Organizational Effectiveness organizations, capping off a 19-year career leading their human resources practices across multiple functional areas and lines of business. Prior to joining Cigna, Hicks held several key executive leadership positions with Capital One Financial, Merck-Medco, and 3M.

Hicks received an MBA from the University of Iowa and a bachelor’s degree from Washington and Lee University. His philanthropic efforts include leadership with Sunrise Community, Inc., where he is a member of their national board of directors, as well as sharing founding responsibilities with his wife for the Farmington Valley NFL Flag Football League in Connecticut.

“In my career, I have found great personal and professional satisfaction working with dynamic and high growth organizations to ensure that every employee is valued and aligned to the success and mission of the company,” Hicks said. “Monogram’s mission and vision was an immediate attraction for me, particularly coming from the health plan experience which constantly highlighted the need to care for complex populations in innovative and different ways. Monogram’s meteoric growth and recent leadership additions make it an exciting company to be part of. I’m proud to support Monogram Health’s employees in their mission to deliver the highest-quality care and improve clinical outcomes for the patients we serve.”

About Monogram Health

# # #

For Media Inquiries:
Kyle Cooksey
Chief Experience Officer
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 10/17/23 Guest User 10/17/23

Monogram Health Welcomes Adam McAnaney to Executive Leadership Team

NASHVILLE, Tenn. (October 17, 2023) — Monogram Health, the nation’s leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease, has hired Adam McAnaney as Chief Legal Officer and Secretary. Adam is a proven leader, and his extensive history of successful executive leadership roles at public companies as well as large-scale healthcare organizations demonstrates his robust capabilities.

“Adam has a clear and expert understanding of the unique needs among our patients, clinicians, investors and health plan partners, and will drive great value for Monogram Health as we continue to expand our proven in-home care delivery model across the U.S.,” said Monogram Health CEO and Co-Founder Mike Uchrin.

Adam served as General Counsel and Secretary for Signify Health, following its acquisition of Remedy Partners. Prior to joining Remedy Partners as General Counsel and Secretary, Adam led multiple strategic initiatives at Aetna, serving as Vice President, Head of Corporate Legal and Corporate Secretary, leading legal support of SEC reporting and disclosure matters, corporate finance, mergers and acquisitions, subsidiary management, licensing, and investments. Prior to assuming leadership roles at Aetna, Adam worked in the New York, Frankfurt, and London offices of Sullivan & Cromwell LLP, where he focused on capital markets and mergers and acquisitions. Adam holds a JD from Columbia Law School as well as a BA from Yale University.

“Throughout my career, I have helped lead some of the nation’s most innovative healthcare companies as they worked to transform the healthcare landscape. Monogram’s value proposition was an immediate draw for me. It is a highly differentiated value-based care platform with a nationally deployed team of clinicians that are making a difference every day in the lives of people impacted by CKD and ESKD,” McAnaney said. “I’m proud to support both Monogram’s mission and its clinicians as they deliver the highest-quality care and improve clinical outcomes for the patients we serve.”

About Monogram Health

Monogram Health is a leading value-based provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions, notably chronic kidney and end stage kidney disease. Through its unique in-home integrated provider services, Monogram Health and its employed providers treat CKD, ESKD and complex metabolic, pulmonary, and cardiovascular diseases. To enable the delivery of value-based care, the company deploys a technology-driven array of clinical programs including comprehensive case management, disease management, utilization management, and medication therapy management to transform the way care is delivered. Based in Nashville, Tenn., and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit here.

# # #

For Media Inquiries:
Kyle Cooksey
Chief Experience Officer
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 7/11/23 Guest User 7/11/23

Monogram Health Achieves NCQA Case Management Accreditation

NASHVILLE, Tenn. (July 11, 2023) — Monogram Health, a leading value-based specialty provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney disease and related metabolic disorders, has achieved accreditation from the National Committee for Quality Assurance (NCQA) for its Complex Case Management program. NCQA awarded the accreditation following its detailed review of Monogram’s case management services for alignment with evidence-based care pathways, processes, and service delivery. This achievement highlights Monogram Health’s commitment to being a clinical leader for patients with polychronic diseases and supporting individuals with complex chronic kidney and end-stage renal disease through innovative home-based care services.

“Patients experiencing chronic kidney or end-stage kidney disease usually have multiple underlying chronic conditions. They’re taking numerous medications and may be dealing with challenges such transportation concerns, access to healthy foods or difficulties managing medical appointments,” said Katrina Cope, Senior Vice President, Strategic Initiatives and Implementations for Monogram Health. “Our complex case management program focuses on the whole person – not just the diagnosis – and ensures that patients and their families receive the information, education and treatment they need to make informed decisions that can meaningfully impact their health and quality of life.”

Monogram Health treats patients with chronic kidney and end-stage kidney disease through their nurse practitioners, supported by nurse care managers and social workers, who guide them through interactions with its multidisciplinary team of nephrologists, cardiologists, internal medicine specialists, geriatricians, dieticians, care coordinators, pharmacists, and additional social workers focused on meeting their care needs. The care team also reviews social determinants of health and other health drivers such as proper nutrition and exercise through regular in-home visits.

“Case Management Accreditation moves us closer to measuring quality across population health management initiatives," said NCQA President Margaret E. O'Kane. "Not only does it add value to existing quality improvement efforts, it also demonstrates an organization's commitment to the highest degree of improving the quality of their patients' care."

NCQA is an independent, not-for-profit organization dedicated to improving health care quality by assessing and reporting on health-related programs. NCQA Accreditation standards are intended to help organizations achieve the highest level of performance possible and create an environment of continuous improvement. Accreditation is awarded to organizations demonstrating strong performance in functions outlined by the NCQA standards for case management accreditation, which are developed with input from expert panels of researchers, employers, purchasers and operators of case management programs, and state and federal regulators.

The case management accreditation is Monogram Health’s second from NCQA. Monogram Health first earned NCQA Population Health Program accreditation in 2020.

About Monogram Health

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage kidney disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health systems and risk-bearing providers to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit monogramhealth.com.

About NCQA

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. In recognition for its leadership in diversity, equity and inclusion, NCQA has won the Excellence in Diversity Award from the Chesapeake Human Resources Association. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make more-informed health care choices. NCQA can be found online at ncqa.org, on Twitter @ncqa, and on LinkedIn at linkedin.com/company/ncqa.

# # #

For Media Inquiries:
Kyle Cooksey
Chief Experience Officer
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 6/21/23 Guest User 6/21/23

Monogram Health Welcomes Aashish Shah, M.D., to Executive Leadership Team

Former HCA Healthcare VP named to newly created Chief Growth Officer role

NASHVILLE, Tenn. (June 21, 2023) — Monogram Health, a specialty provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney disease and related metabolic disorders, has hired Aashish Shah, M.D., as Chief Growth Officer. Dr. Shah brings nearly two decades of executive and health care experience to the role, where he will lead the continued rapid and widespread growth of Monogram’s innovative in-home care delivery model.

“With his impressive background in physician alignment, patient acquisition, strategy and value-based contracting, Dr. Shah is uniquely positioned to direct the continued expansion of our geographic clinical footprint as well as growing our portfolio of value-based client partners,” said Monogram Health CEO Mike Uchrin. “We are delighted to welcome a third physician executive to our leadership team as we drive physician-led, in-home value-based care to improve access, outcomes and affordability for our patients.”

Prior to joining Monogram, Dr. Shah served as corporate vice president for strategy and product innovation for payer contracting and alignment at Nashville-based HCA Healthcare. Prior to that, he was president/CEO of Provision Health Partners and president of Provision CARES Nashville. Early in his career, Dr. Shah also served as regional medical director for the Texas Department of State Health Services and as chief physician of preparedness for the City of Houston.

Dr. Shah earned his medical degree from UT Health San Antonio and received his juris doctorate from the University of Houston Law Center. As a board-certified OBGYN and a fellow of the American College of Obstetricians and Gynecologists, Dr. Shah has practiced in public, private and academic settings. In 2010, Dr. Shah became the first-ever executive fellow at Texas Children’s Hospital Integrated Delivery System, where he worked on enhancing system quality, developing service lines and improving health plan operations.

“I’m eager to put my clinical experience and business acumen to work in support of Monogram’s inspiring mission to transform the way evidence-based care is delivered to millions of people nationwide living with polychronic diseases,” Dr. Shah said. “I look forward to supporting the expansion of this innovative, in-home care delivery model that has proven so successful in driving better health outcomes and affordability for patients across the 35 states it serves.”

About Monogram Health

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and
technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit here.

# # #

For Media Inquiries:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 6/5/23 Guest User 6/5/23

Monogram Health Welcomes Casey McKeon to Executive Leadership Team

Former Cigna and Humana executive named chief operating officer of fast-growing, value-based specialty provider for patients with kidney and polychronic conditions

NASHVILLE, Tenn. (June 5, 2023) — Monogram Health, a specialty provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney disease and related metabolic disorders, has hired Casey McKeon as chief operating officer. McKeon brings more than two decades of operations management, government-sponsored health plan and executive leadership experience to the role, in which he will be responsible for bolstering the continued successful deployment of Monogram’s innovative in-home care delivery model.

“Casey is a demonstrated leader with notable experience driving systemic growth and operational efficiency,” said Monogram Health CEO Mike Uchrin. “His extensive background managing complex health plan programs for patients with complex conditions – combined with his focus on delivering results that improve quality and affordability for patients and providers alike – deeply aligns with our own mission and vision of transforming kidney and polychronic care delivery across America.”

Prior to joining Monogram, McKeon served as general manager of strategy & operations for Cigna’s government business segment. Prior to that, he was president of CareAllies, a Cigna company, and was part of the integration team that shepherded the Cigna-HealthSpring acquisition, eventually being named COO and market manager for the Mid-Atlantic region. McKeon also served as a director of Medicare at Humana. He earned his bachelor’s degree in marketing and Spanish language and literature from the University of Notre Dame - Mendoza College of Business.

“I have been impressed with Monogram’s rapid growth and noble mission since my first exposure to the company,” McKeon said. “Their innovative model is truly transforming care delivery and improving quality of life for tens of thousands of Americans navigating multiple chronic diseases. I am proud to become part of the team and look forward to contributing to the company’s continued success.”

About Monogram Health

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and
technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 35 states and all insurance products. To learn more about Monogram Health, please visit here.

Guest User 2/7/23 Guest User 2/7/23

Monogram Health’s In-Home Services Now Available to More Older Adults Living with Chronic Kidney Conditions

NASHVILLE, Tenn. (Feb. 7, 2023) — Monogram Health, a specialty provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions, is now available to Cigna Medicare Advantage customers nationwide.

Eligible customers navigating chronic kidney and end-stage renal disease, as well as comorbid metabolic disorders, will benefit from access to Monogram’s national nephrology practice and other specialized resources, including in-home primary and specialty care visits, medication management, dialysis and transplant coordination, and social services.

In addition, the organizations have expanded their value-based care agreement. Monogram will assume full financial risk for the Cigna Medicare Advantage customers it serves, allowing for improved affordability, along with enhanced patient outcomes.

“Chronic kidney disease affects more than 1 in 7 adults, or about 37 million people across the United States. It often is linked to other chronic conditions that contribute to increased challenges in maintaining overall health and access to care,” said Cigna Medicare’s Chief Medical Officer, J.B. Sobel, MD, MPH, MBA. “The decision to expand our agreement with Monogram further demonstrates our commitment to improving the overall health, well-being and peace of mind for our Medicare customers.”

“We’re happy to extend our highly successful and innovative model of evidence-based care delivery to Cigna Medicare Advantage customers nationwide,” said Monogram CEO Mike Uchrin. “We’re committed to transforming the way nephrology, primary care and chronic condition treatment are delivered to patients in the comfort of their own homes. We’re pleased to provide added value to Cigna Medicare Advantage customers who can benefit from these specialized care services that improve quality of life, while improving affordability across the health care continuum.”

About Monogram Health

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and
technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 34 states and all insurance products. To learn more about Monogram Health, please visit here.

# # #

For Media Inquiries:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 1/9/23 Guest User 1/9/23

Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care Model

Milestone funding from leading strategic and financial investors will help accelerate company’s mission to measurably improve outcomes for patients living with polychronic conditions, including chronic kidney and end-stage renal disease

NASHVILLE, Tenn. (Jan. 9, 2023) — Monogram Health, a value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease, today announced it has closed on $375 million of new funding. This milestone growth funding round included investments from leading strategic investors CVS Health, Cigna Ventures, Humana, Memorial Hermann Health System, and SCAN, as well as from both new and existing financial investors including TPG Capital, Frist Cressey Ventures, Heritage Group, Pura Vida Investments, and Norwest Venture Partners, among others.

Monogram will use the funding proceeds to continue to support the rapid and widespread deployment of the company’s innovative in-home kidney and polychronic care delivery model as well as its technology-driven array of evidence-based clinical services, which include complex case and disease management, utilization management, and medication therapy management. This innovative model of care transforms the way health care is delivered for those with kidney disease as well as comorbid metabolic disorders and has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum, improving access and affordability for all.

“Monogram is bringing an innovative, integrated approach to in-home care delivery that is increasing access and engagement, lowering cost, and driving better outcomes for patients managing chronic kidney disease,” said Todd Sisitsky, President of TPG and Co-Managing Partner of TPG Capital. “We’re proud to continue to partner with Mike and the Monogram team, along with a world-class syndicate of strategic investors, as they transform existing care models and build a value-based healthcare system that truly serves the needs of all patients and communities nationwide,” added Kendall Garrison, Partner at TPG Capital.

“At Monogram Health we actively manage patients’ kidney disease and a wide range of acute and chronic conditions using our proprietary, evidence-based protocols and technology,” said Mike Uchrin, CEO and Co-Founder of Monogram Health. “Everything we do is designed to improve access to health care and health outcomes for polychronic patients by supporting their individual needs in their own homes, transforming the patient experience, especially for those who have been historically underserved.”

For the more than 37 million American adults living with chronic kidney disease, access to the type of specialized care that Monogram provides is critical. Monogram's transformative, high-touch and in-home model is driven by the company's extensive market-based teams of clinicians, led by physicians and nurse practitioners who are supported by registered nurses, social workers, pharmacists, and care management teams. These providers and clinical experts are further bolstered by utilization management teams that focus in and around hospitalizations and discharge management, personalizing the experience and care for Monogram patients in nearly 4,000 U.S. cities across 34 states.

With its new strategic syndicate, Monogram’s investor base now serves over 30% of Medicare Advantage members nationwide and supports upwards of 40% of the U.S. population, uniquely positioning the company to serve those living with chronic kidney disease and their related metabolic disorders.

“We founded Monogram Health with a particular eye on health equity,” said Senator Bill Frist, M.D., Monogram’s board chair and Partner with Frist Cressey Ventures. “Kidney disease impacts a disproportionate share of disadvantaged communities and communities of color. Monogram has made bold strides in offering patients and families enhanced access to much needed health services, while substantially improving the overall affordability of their care. This latest milestone growth funding round with substantive new and existing partners is driven by our disciplined commitment to, and demonstration of, outstanding clinical results. These better quality outcomes for patients are made possible by our transformative approach to offering in-home, evidence-based nephrology and polychronic care. I’m proud to work alongside Monogram’s focused leadership team to continue to propel the company as the sustainable clinical leader for patients across the United States.”

BofA Securities acted as sole placement agent and Cravath, Swaine & Moore LLP served as legal counsel to Monogram in connection with the transaction.

About Monogram Health

Monogram Health is a leading value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with polychronic conditions. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, TPG Capital, Norwest Venture Partners, as well as other leading strategic and financial investors, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 34 states and all insurance products. To learn more about Monogram Health, please visit here.

# # #

For Media Inquiries:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.485.5999

Guest User 11/3/22 Guest User 11/3/22

AdventHealth Partners with Monogram Health to Improve Health Outcomes for Those Impacted by Chronic Kidney Disease

NASHVILLE, Tenn. (November 3, 2022) — Monogram Health, a value-based specialty provider of in-home nephrology, primary care and benefit management services for individuals with chronic kidney and end-stage renal disease, today announced it has been selected by AdventHealth, one of the nation's largest faith-based health systems, as a partner to improve the health outcomes of patients impacted by chronic kidney disease. The partnership connects Monogram’s specialized MSO kidney care teams with AdventHealth providers to slow the progression of chronic kidney and end-stage renal disease.

“Monogram Health’s broad range of kidney-focused services will serve as a valuable resource to AdventHealth providers in the shared pursuit of improved clinical outcomes,” said Thomas Diller, M.D., chief medical officer of AdventHealth’s Population Health Services Organization. “Monogram’s evidence-based, in-home care management model offers a blueprint for providers as they work to delay the progression of kidney disease, prevent complications and appropriately prepare and manage patient needs.”

Through the partnership, Monogram Health supports AdventHealth across its Florida markets, serving members enrolled in AdventHealth Advantage Plans MA, AdventHealth Employee Plan, AdventHealth Advantage Commercial Plans and AdventHealth Well 65+.

Monogram’s transformative, high-touch model has been shown to improve patient outcomes, experience and quality of life while reducing medical costs. Monogram is working with AdventHealth’s providers to coordinate care for patients, offering services including care coordination with nephrology specialists and primary care providers as well as dialysis, transplant, palliative care and social services; family counseling; in-home care management; medication management; advance care planning; nutrition management; referral management; remote monitoring/biometrics; and telehealth. Monogram services are available at no cost to patients.

“We’re proud to bring our unique kidney care model and specialized expertise to AdventHealth’s providers and serve as an extension of their patient-centered practices,” said Monogram Health CEO Michael Uchrin. “Our organizations share a commitment to improving the quality of life for those we serve through the delivery of whole-person, best-in-class care. Through this partnership, Monogram will support AdventHealth patients and families to assist them in maximizing their health for happier, more fulfilling lives.”

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans and risk-bearing providers to care for patients across 34 states and all insurance products. To learn more about Monogram Health, please visit here.

About AdventHealth

With a sacred mission of Extending the Healing Ministry of Christ, AdventHealth is a connected system of care for every stage of life and health. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies and hospice centers provide individualized, wholistic care. A shared vision, common values, focus on whole-person health and commitment to making communities healthier unify the system's more than 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states. For more information, visit adventhealth.com/news.

# # #

Media Contact:
Kyle Cooksey, kyle.cooksey@monogramhealth.com, 615-510-6492

Guest User 10/28/22 Guest User 10/28/22

Monogram Health Again Earns Prestigious HITRUST Certification for Demonstrated Excellence in Protecting Sensitive Patient Health Information

NASHVILLE, Tenn. (Oct. 28, 2022) — Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease, today announced it has again achieved HITRUST CSF Certification, the gold standard for information risk management and compliance.

The successful review and recertification notice follows detailed inspection of the company’s systems and controls for protecting electronic health records and other sensitive data that demonstrates exemplary safety practices. The Nashville-based company first earned HITRUST CSF Certification in 2020 for its notable security protocols.

“Improving the health outcomes and quality of life for those we serve is our mission every day. The acknowledgment from HITRUST helps illuminate the care and respect we take to ensure the privacy and protection of our patients’ data,” said Monogram CEO Mike Uchrin. “We’re proud to have earned this recertification, which further highlights the impact of our daily work to transform the way health care is delivered for those living with kidney disease and its related co-morbidities.”

Monogram’s newest HITRUST CSF Certification validates the company’s policies and procedures not only meet, but have exceeded key, industry-defined requirements; take the most proactive approach to data protection; and adhere to the highest information security standards.

“Monogram’s evidence-based, in-home care model is powered by a suite of technology-enabled clinical services. Our industry-leading technology and HIPAA-compliant platforms include a proprietary cloud-based care management EHR platform, a full-scale data warehouse and AI-enabled analytics that are improving outcomes and quality of life for kidney disease patients in a host of different ways,” said Brian Loflin, Monogram's Chief Technology Officer. “This HITRUST CSF Certification marks a special point of pride for our innovative model of care and validates our unwavering commitment to the safety of our patients.”

About Monogram Health

Monogram Health is a next-generation, value-based chronic condition provider serving patients living with chronic kidney and end-stage renal disease and related metabolic disorders. Monogram seeks to fill systemic gaps and transform the way nephrology, primary care and chronic condition treatment are delivered. Monogram’s innovative, in-home approach utilizes a suite of technology-enabled clinical services, including benefit management and complex care coordination services that improve health outcomes while lowering medical costs across the healthcare continuum. By focusing on increasing access to evidence-based care pathways and addressing social determinants of health, Monogram has emerged as an industry leader in championing greater health equity and slowing the progression of chronic kidney disease. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 33 states and all insurance products. To learn more about Monogram Health, please visit here.

About HITRUST

Since it was founded in 2007, HITRUST has championed programs that safeguard sensitive information and manage information risk for global organizations across all industries and throughout the third-party supply chain. In collaboration with privacy, information security and risk management leaders from the public and private sectors, HITRUST develops, maintains and provides broad access to its widely adopted common risk and compliance management frameworks, related assessments and assurance methodologies. For more information, visit here.

# # #

Media Contact:

Kyle Cooksey, kyle.cooksey@monogramhealth.com, 615-510-6492

Guest User 10/26/22 Guest User 10/26/22

Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States

LOUISVILLE, Ky. – October 26, 2022 — Kidney care provider Monogram Health and leading health and well-being company Humana Inc. (NYSE: HUM) have announced a new value-based care agreement for most Humana Medicare Advantage HMO and PPO plan members in four states who live with chronic kidney disease.

Value-based care focuses on the collaboration and coordination of all aspects of a patient’s care, and this agreement is designed to help improve quality of life for the members who have chronic kidney disease in Tennessee, Alabama, Mississippi and Louisiana. The members can now access Monogram’s specialized resources, which include in-home primary and specialty care visits, medication management, dialysis and transplant coordination, palliative care, and social services.

“With millions of Americans living with chronic kidney disease and the number continuing to grow, Humana is committed to increasing access to evidence-based, multi-specialty kidney care to ensure our members have the services they need without having to leave home,” said Carl Daley, Humana Senior Vice President of Retail Strategy and Operations. “Building on our existing relationship with Monogram is an important way we can provide the highest levels of support and access to care for our members.”

“This important step forward strengthens our already impactful relationship with Humana, allowing us to continue our mission-driven work of transforming care for people with chronic conditions,” said Monogram CEO Mike Uchrin. “We’re proud Monogram can now bring even more value to Humana and the members they serve.”

Humana has an extensive and growing value-based care presence. As of June 30, 2022, Humana has more than 3.2 million individual Medicare Advantage and commercial members who are cared for by 75,600 primary care providers in more than 1,000 value-based relationships across 46 states and Puerto Rico. Humana’s total Medicare Advantage membership is approximately 5.1 million members, which includes members affiliated with providers in value-based and standard Medicare Advantage settings.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

Annual reports to stockholders;
Securities and Exchange Commission filings;
Most recent investor conference presentations;
Quarterly earnings news releases and conference calls;
Calendar of events; and

· Corporate Governance information.

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 33 states and all insurance products. To learn more about Monogram Health, please visit here.

###

Other providers are available in the Humana network. Provider may also contract with other plan sponsors.

FOR MORE INFORMATION, CONTACT:

Lisa Dimond
Humana Corporate Communications
832-330-4702
ldimond@humana.com

Kyle Cooksey
Monogram Corporate Communications
615-510-6492
kyle.cooksey@monogramhealth.com

Guest User 10/12/22 Guest User 10/12/22

Point32Health and Monogram Health Collaborate to Improve Chronic Kidney Care

Tufts Health Plan and Harvard Pilgrim Health Care commercial members to benefit from early in-home access to care and benefit management services

CANTON, Mass. and NASHVILLE, Tenn. (October 12, 2022) — Point32Health, the parent company of Tufts Health Plan and Harvard Pilgrim Health Care, today announced a collaboration with Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. Point32Health and Monogram will work to increase access to early kidney care for Harvard Pilgrim Health Care and Tufts Health Plan commercial members.

Through the collaboration, Monogram Health will assume full financial risk for Point32Health’s members with kidney disease, delivering industry-leading in-home specialty care services promoting better patient outcomes while improving affordability.

“Point32Health is committed to delivering innovative services, tailored care management and support to the members we serve,” said Cain Hayes, president and CEO of Point32Health. “Working with Monogram Health, we will ensure our commercial members receive best-in-class kidney care with the goal of slowing disease progression and providing our members and provider community access to specialty care for better health outcomes.”

“This powerful collaboration with Point32Health furthers Monogram’s mission to transform the way health care is delivered for those with kidney disease so they can lead healthier, happier, and more fulfilling lives,” said Monogram Health board chair Bill Frist, M.D., who graduated from Harvard Medical School before becoming a heart and lung transplant surgeon and later U.S. Senate majority leader. “By combining Monogram's innovative, in-home, evidence-based care delivery approach with one of New England’s most iconic nonprofit health care organizations, we can dramatically improve patient outcomes and quality of life for those affected by kidney disease.”

The collaboration also includes a research component between Monogram and the Harvard Pilgrim Health Care Institute’s Department of Population Medicine, a unique collaboration between Harvard Pilgrim Health Care and Harvard Medical School focused on innovative teaching and research to address health care issues.

More than 37 million Americans live with chronic kidney disease with communities of color being disproportionately impacted, as African Americans are about 3.5 times more likely and Hispanics approximately twice as likely to develop end-stage renal disease (https://adr.usrds.org/2021).

Point32Health and Monogram Health are exploring opportunities to expand the program across other lines of Point32Health’s business.

# # #

About Point32Health

Point32Health is a leading health and wellbeing organization, delivering an ever-better health care experience to everyone in our communities. Building on the quality, nonprofit heritage of our founding organizations, Tufts Health Plan and Harvard Pilgrim Health Care, we leverage our experience and expertise to help people find their version of healthier living through a broad range of health plans and tools that make navigating health and wellbeing easier. Our programs take a 360-degree view of health for our members—no matter their age, health, race, identity or income. Our Institute works to improve population health—and our Foundation works with communities to support, advocate and advance healthier lives for everyone. We use empathy to understand what’s important to those we serve, always making their priorities our own. And we work to guide and empower people by bringing together wide-ranging partners and perspectives to create new approaches that make a real difference for our community, our industry and our 2.2 million members across New England. For more information, click here.

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans and value-based providers to care for patients across 33 states and all insurance products. To learn more about Monogram Health, please visit here.

Media Contacts:
Philip Tracey, Philip.Tracey@point32health.org
Kyle Cooksey, kyle.cooksey@monogramhealth.com, 615-485-5999

Guest User 9/13/22 Guest User 9/13/22

Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease

NASHVILLE, Tenn., and PHILADELPHIA, Pa. (Sept. 13, 2022) — Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease, today announced a $2.5 million gift to the Leonard Davis Institute of Health Economics at the University of Pennsylvania (Penn LDI). The donation will be used to establish the Monogram Health Chronic Kidney Disease Fund, which will support a collaborative research initiative at Penn LDI aimed at improving clinical outcomes of individuals with chronic kidney disease.

Penn LDI, located in Philadelphia, is dedicated to data-driven, policy-focused research that improves the nation’s health and health care. The new Research Initiative on Improving Management of Chronic Kidney Disease will tap into Penn LDI’s expertise and reputation as an unbiased academic authority on innovating and improving health care delivery while aligning with Monogram Health’s commitment to measurably improve outcomes for individuals living with kidney disease. The multi-year project will focus on rapid turnaround, high-impact research of evidence-based care pathways that will transform the delivery of care for individuals with progressed chronic kidney and end-stage renal disease.

“This research initiative will enable new and important contributions that will advance the field and health care’s capacity to effectively identify, manage, and improve outcomes for patients with kidney disease,” said Senator Bill Frist, M.D., Monogram Health’s board chairman. “We’re grateful for the opportunity to partner with such an esteemed research entity as Penn LDI to study treatment approaches with the goal of enhancing evidence-based kidney care. We believe this work will benefit millions of Americans, particularly minority populations who have a higher propensity to develop progressed kidney disease.”

Among the more than 37 million people in the U.S. living with CKD, communities of color are disproportionately affected, with rates of CKD almost four times as high among African Americans. Penn LDI will rely on its substantial expertise in CKD and transplantation to focus on identifying drivers of CKD progression and addressing barriers to the adoption of optimal, evidence-based therapies.

“This commitment from Monogram Health signals a step forward in equitable health care access and innovative research, bringing meaningful resources to Penn LDI and its partnerships across the University," says Wharton School Dean Erika James. "Conjuring the lives impacted and discoveries that will stem from this contribution fills the Wharton community with pride to be a part of Penn LDI and deep gratitude for this generous gift."

“Thanks to Monogram Health’s generous gift and commitment to innovation and health equity, our team will be empowered to conduct important, independent research focused on improving health care delivery for patients with kidney disease,” said Rachel M. Werner, M.D., PhD, executive director of Penn LDI. “It will also allow for the vital step of sharing our findings with stakeholders who can use it, to maximize the research’s impact on health policy and innovation in chronic kidney disease care. We are very appreciative of Monogram’s interest in advancing research in this important area.”

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 33 states and all insurance products. To learn more about Monogram Health, please visit here.

About Penn LDI

Since 1967, the Leonard Davis Institute of Health Economics at the University of Pennsylvania (Penn LDI) has been the country’s leading university institute dedicated to data-driven, policy-focused research that improves our nation’s health and health care. Penn LDI connects all twelve of Penn’s schools, the University of Pennsylvania Health System, and the Children’s Hospital of Philadelphia through its more than 300 Penn faculty who are LDI Senior Fellows. Penn LDI’s work focuses on some of the most pressing challenges facing our nation’s health system today, including increasing health care access, improving health equity, and improving care for those with chronic conditions.

Contact information: Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.510.6492

Thomas Lilly 6/28/22 Thomas Lilly 6/28/22

Monogram Health Adds Bhavesh Shah to Executive Leadership Team

NASHVILLE, Tenn. (June 28, 2022) — Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease, has hired Bhavesh Shah as Chief Financial Officer. Shah brings two decades of financial leadership and growth stage executive experience to the role, where he will lead Monogram’s financial operations, including actuarial and medical economics, treasury, financial planning and analysis, and audit.

“We’re thrilled to welcome Bhavesh to the executive leadership team. His extensive experience managing the complex financial operations of growth stage as well as scaled health care companies is a tremendous asset for Monogram as we transform how care is delivered for patients with kidney disease across America,” said Monogram Health CEO Mike Uchrin. “With his background in investment banking, value-based care, and in-home care delivery, Bhavesh brings a distinct perspective that will enhance our daily efforts to maximize the health of all people living with kidney disease.”

Prior to joining Monogram, Shah served as the CFO and executive vice president for Compassus. Before that, he spent more than eight years leading financial operations for Fortune 500 health care companies, including roles as vice president of FP&A at CVS Health’s retail business, and vice president and CFO of Aetna’s consumer health products and services business where he oversaw Aetna’s value-based care and complex care management programs. Earlier in his career, Shah served as a health care investment banker at Lehman Brothers and Barclays Capital. He also served five years in the U.S. Army, rising to the rank of Captain. Shah holds an MBA from the Massachusetts Institute of Technology and a bachelor’s degree in engineering from the University of Connecticut.

“I’m inspired by Monogram’s demonstrated success in lowering medical expense and commitment to improving the quality of life for patients across the 34 states it serves,” Shah said. “I’m excited to put my expertise to work as part of this innovative, in-home care delivery model.”

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans and value-based providers to care for patients across 34 states and all insurance products. To learn more about Monogram Health, please visit here.

Media Contact:

Kyle Cooksey, kyle.cooksey@monogramhealth.com, 615-510-6492

Guest User 5/16/22 Guest User 5/16/22

Monogram Health Adds Karen Abbott to Executive Leadership Team

Karen Abbott, Chief Administrative Officer and Chief Compliance Officer of Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with CKD and ESRD — Karen Abbott, Chief Administrative Officer and Chief Compliance Officer of Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease.

NASHVILLE, Tenn. (May 16, 2022) — Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease, has hired Karen Abbott as Chief Administrative Officer and Chief Compliance Officer. Abbott brings more than three decades of experience to the roles, where she leads Monogram’s human resources, legal, compliance and risk teams.

“Karen is a demonstrated leader, and her long history of supporting growth stage and private equity-backed health care companies underscores her sharp acumen for the complexities of our rapidly evolving industry,” said Monogram Health CEO Mike Uchrin. “Karen has a keen understanding of the unique needs and dynamics among our patients, health plan partners, clinicians and employees. She will be a key leader in our daily efforts to transform the way care is delivered to Americans living with kidney disease.”

A Nashville resident for more than 30 years, Abbott most recently served as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary at American Addiction Centers. While at AAC, she advised the company on all aspects of human resources, risk management and regulatory matters, while also managing operations, compliance, risk, and all legal functions for the treatment facilities and corporate office.

“Every day, Monogram’s employees make a positive difference in the lives of people impacted by kidney disease,” Abbott said. “I’m honored to contribute my expertise to support Monogram’s mission and our colleagues nationwide as they deliver the highest-quality, evidence-based care in our patients’ homes.”

# # #

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital, Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 34 states and all insurance products. To learn more about Monogram Health, please visit here.

Thomas Lilly 12/16/21 Thomas Lilly 12/16/21

Former CMS Administrator and Monogram Board member, Seema Verma, make MOST-READ STRATEGY ARTICLES OF 2021 with HealthLeaders

HealthLeaders Strategy Editor Melanie Blackman speaks with Seema Verma, a health policy expert and consultant, and former administrator of the Centers for Medicare and Medicaid Services, who shares what drives her to work in healthcare policy, her goals in serving as board of director for both Lumeris and Monogram Health, her thoughts on the Biden Administration, and advice for future leaders.

Podcast can be listened to here.

Thomas Lilly 12/14/21 Thomas Lilly 12/14/21

Monogram Health Announces Chief Operating Officer Chris Chi selected to the Nashville Health Care Council Fellows Class of 2022

NASHVILLE, Tenn. (December 14, 2021) — Monogram Health today announced that its Chief Operating Officer, Chris Chi, has been selected as a member of the Nashville Health Care Council Fellows Class of 2022. As a passionate health care operations leader, Chi brings two decades of experience leading managed care organizations and value-based healthcare providers.

“As a graduate of the 2016 Nashville Healthcare Council Fellows class, I couldn’t be any prouder of Chris and his acceptance into the 2022 class,” said Monogram Health CEO Michael Uchrin. “The program connected me with Senator Bill Frist, M.D., with whom I co-founded Monogram Health. Now, we are the leading value-based provider, transforming care for individuals with kidney disease. I look forward to what Chris will contribute to this year’s class of health care leaders.”

Chi has previously served as a senior executive of managed care organizations, physician practice groups, hospital systems and behavioral health providers. At Monogram Health, he has led the formation of industry-leading clinical programs that manage the longitudinal care of those with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD), raising quality outcomes while eliminating unnecessary utilization and spending.

Chi received his B.A. from Harvard University and his J.D. from the University of Virginia. In addition to leading health care operations, Chi has practiced health care transactional law in private practice and with publicly held healthcare organizations.

The Nashville Health Care Council Fellows program annually selects health care leaders in order to foster innovative and forward-looking solutions to challenges facing the American health care system.

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital,Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 20 states and all insurance products. To learn more about Monogram Health, please visit here.

Contact information:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.510.6492

Thomas Lilly 11/9/21 Thomas Lilly 11/9/21

Monogram Health Names Kyle Cooksey, SVP, Marketing and Communications

NASHVILLE, Tenn. (Nov. 9, 2021) — Monogram Health today announced it has named Kyle Cooksey senior vice president, marketing and communications. Cooksey brings two decades of experience in health care operations, innovation, and marketing to the rapidly growing value-based provider of in-home nephrology, primary care and benefit management services for individuals with chronic kidney and end-stage renal disease.

In the newly established role, Cooksey will lead marketing and strategic communications. He will also manage and nurture relationships with key stakeholders.

“Kyle’s understanding of the unique needs and dynamics among our patients, health plan partners, clinicians, and industry groups will help drive our mission of transforming care for kidney disease patients,” said Monogram Health CEO Michael Uchrin. “Anyone who knows Kyle immediately recognizes his genuine and heartfelt compassion for the change our patients need and deserve. Kyle’s ability to authentically connect with a diverse group of constituents will bring great value as we tell our story and work to change the lives of millions of Americans with kidney disease.”

A native of Texas, Cooksey most recently served as senior vice president, renal physician services, at Monogram Health, where he led the formation of Monogram Kidney Care, focused on providing in-home nephrology care for patients. He previously served as president of CareThrough, part of the HealthChannels family of business lines, where he developed a care management service line for hospital clients.

Cooksey earned a dual degree in marketing and management from the Hankamer School of Business at Baylor University in Waco, Texas.

“Our team works tirelessly and passionately to engage with patients and their family members to bring transformative care in the comfort of their own homes. In every interaction, we’re nurturing relationships and building trust,” Cooksey said. “I look forward to bringing our mission to life as we tell Monogram’s story.”

About Monogram Health

Monogram Health is a leading value-based provider of in-home nephrology, primary care, and benefit management services for individuals with chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management to transform the way health care is delivered for those with kidney disease. This innovative model of care has been shown to dramatically improve patient outcomes and quality of life while reducing medical costs across the health care continuum. Based in Nashville, Tennessee, and privately held by Frist Cressey Ventures, Norwest Venture Partners, and TPG Capital,Monogram Health has numerous value-based partnerships with leading health plans to care for patients across 20 states and all insurance products. To learn more about Monogram Health, please visithere.

Contact information:
Kyle Cooksey
SVP, Marketing and Communications
Monogram Health
kyle.cooksey@monogramhealth.com
615.510.6492